vs
Protalix BioTherapeutics, Inc.（PLX）与Outdoor Holding Co（POWW）财务数据对比。点击上方公司名可切换其他公司
Outdoor Holding Co的季度营收约是Protalix BioTherapeutics, Inc.的1.5倍（$13.4M vs $9.1M），Outdoor Holding Co净利率更高（16.7% vs -60.3%，领先77.0%），Protalix BioTherapeutics, Inc.同比增速更快（-49.9% vs -54.1%），Outdoor Holding Co自由现金流更多（$5.0M vs $1.6M）
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
Vista Outdoor Inc.（原代码POWW）是美国户外行业企业，主营射击运动器材与户外产品两大业务板块，是拥有超过40个品牌与子品牌的多品牌户外用品集团，负责产品的设计、生产与市场推广。
PLX vs POWW — 直观对比
营收规模更大
POWW
是对方的1.5倍
$9.1M
营收增速更快
PLX
高出4.2%
-54.1%
净利率更高
POWW
高出77.0%
-60.3%
自由现金流更多
POWW
多$3.4M
$1.6M
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $9.1M | $13.4M |
| 净利润 | $-5.5M | $2.2M |
| 毛利率 | 49.4% | 87.1% |
| 营业利润率 | -51.1% | 14.7% |
| 净利率 | -60.3% | 16.7% |
| 营收同比 | -49.9% | -54.1% |
| 净利润同比 | -184.8% | 108.5% |
| 每股收益（稀释后） | $-0.06 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLXPOWW
| Q4 25 | $9.1M | $13.4M | ||
| Q3 25 | $17.9M | $12.0M | ||
| Q2 25 | $15.7M | $11.9M | ||
| Q1 25 | $10.1M | $12.6M | ||
| Q4 24 | $18.2M | $12.5M | ||
| Q3 24 | $18.0M | $12.0M | ||
| Q2 24 | $13.5M | $12.3M | ||
| Q1 24 | — | $-50.7M |
净利润PLXPOWW
| Q4 25 | $-5.5M | $2.2M | ||
| Q3 25 | $2.4M | $1.4M | ||
| Q2 25 | $164.0K | $-6.5M | ||
| Q1 25 | $-3.6M | $-77.5M | ||
| Q4 24 | $6.5M | $-26.1M | ||
| Q3 24 | $3.2M | $-12.4M | ||
| Q2 24 | $-2.2M | $-14.8M | ||
| Q1 24 | — | $-5.2M |
毛利率PLXPOWW
| Q4 25 | 49.4% | 87.1% | ||
| Q3 25 | 53.4% | 87.1% | ||
| Q2 25 | 62.5% | 87.2% | ||
| Q1 25 | 19.1% | 87.5% | ||
| Q4 24 | 78.7% | 87.4% | ||
| Q3 24 | 53.4% | 86.9% | ||
| Q2 24 | 29.8% | 85.8% | ||
| Q1 24 | — | — |
营业利润率PLXPOWW
| Q4 25 | -51.1% | 14.7% | ||
| Q3 25 | 11.9% | 5.9% | ||
| Q2 25 | 7.5% | -50.7% | ||
| Q1 25 | -41.0% | -213.6% | ||
| Q4 24 | 39.6% | -163.8% | ||
| Q3 24 | 22.2% | -50.3% | ||
| Q2 24 | -18.0% | -50.8% | ||
| Q1 24 | — | — |
净利率PLXPOWW
| Q4 25 | -60.3% | 16.7% | ||
| Q3 25 | 13.2% | 11.7% | ||
| Q2 25 | 1.0% | -54.5% | ||
| Q1 25 | -35.8% | -614.5% | ||
| Q4 24 | 35.6% | -208.7% | ||
| Q3 24 | 18.0% | -103.7% | ||
| Q2 24 | -16.4% | -120.2% | ||
| Q1 24 | — | 10.3% |
每股收益（稀释后）PLXPOWW
| Q4 25 | $-0.06 | $0.01 | ||
| Q3 25 | $0.03 | $0.01 | ||
| Q2 25 | $0.00 | $-0.06 | ||
| Q1 25 | $-0.05 | $-0.67 | ||
| Q4 24 | $0.10 | $-0.23 | ||
| Q3 24 | $0.03 | $-0.11 | ||
| Q2 24 | $-0.03 | $-0.13 | ||
| Q1 24 | — | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.7M | $69.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $48.2M | $237.3M |
| 总资产 | $82.3M | $271.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PLXPOWW
| Q4 25 | $14.7M | $69.9M | ||
| Q3 25 | $13.6M | $65.7M | ||
| Q2 25 | $17.9M | $63.4M | ||
| Q1 25 | $19.5M | $30.2M | ||
| Q4 24 | $19.8M | $31.9M | ||
| Q3 24 | $27.4M | $33.5M | ||
| Q2 24 | $23.4M | $50.8M | ||
| Q1 24 | — | $55.6M |
股东权益PLXPOWW
| Q4 25 | $48.2M | $237.3M | ||
| Q3 25 | $52.9M | $235.4M | ||
| Q2 25 | $49.9M | $222.5M | ||
| Q1 25 | $45.2M | $222.0M | ||
| Q4 24 | $43.2M | $299.6M | ||
| Q3 24 | $32.4M | $325.6M | ||
| Q2 24 | $28.6M | $342.5M | ||
| Q1 24 | — | $358.0M |
总资产PLXPOWW
| Q4 25 | $82.3M | $271.7M | ||
| Q3 25 | $82.3M | $270.3M | ||
| Q2 25 | $78.5M | $269.5M | ||
| Q1 25 | $73.9M | $297.3M | ||
| Q4 24 | $73.4M | $355.4M | ||
| Q3 24 | $61.6M | $368.9M | ||
| Q2 24 | $91.5M | $398.6M | ||
| Q1 24 | — | $403.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.0M | $5.7M |
| 自由现金流经营现金流 - 资本支出 | $1.6M | $5.0M |
| 自由现金流率自由现金流/营收 | 17.8% | 37.6% |
| 资本支出强度资本支出/营收 | 4.4% | 4.8% |
| 现金转化率经营现金流/净利润 | — | 2.55× |
| 过去12个月自由现金流最近4个季度 | $-13.6M | $-2.3M |
8季度趋势，按日历期对齐
经营现金流PLXPOWW
| Q4 25 | $2.0M | $5.7M | ||
| Q3 25 | $-3.7M | $3.2M | ||
| Q2 25 | $-5.2M | $-6.7M | ||
| Q1 25 | $-5.1M | $-1.5M | ||
| Q4 24 | $4.0M | $1.3M | ||
| Q3 24 | $4.1M | $-9.3M | ||
| Q2 24 | $-3.6M | $-547.5K | ||
| Q1 24 | — | $4.3M |
自由现金流PLXPOWW
| Q4 25 | $1.6M | $5.0M | ||
| Q3 25 | $-4.2M | $2.5M | ||
| Q2 25 | $-5.7M | $-7.6M | ||
| Q1 25 | $-5.4M | $-2.3M | ||
| Q4 24 | $3.6M | $720.3K | ||
| Q3 24 | $4.0M | $-10.6M | ||
| Q2 24 | $-3.8M | $-1.3M | ||
| Q1 24 | — | $1.4M |
自由现金流率PLXPOWW
| Q4 25 | 17.8% | 37.6% | ||
| Q3 25 | -23.7% | 21.0% | ||
| Q2 25 | -36.2% | -63.8% | ||
| Q1 25 | -53.0% | -18.6% | ||
| Q4 24 | 19.6% | 5.8% | ||
| Q3 24 | 22.4% | -88.3% | ||
| Q2 24 | -28.1% | -11.0% | ||
| Q1 24 | — | -2.8% |
资本支出强度PLXPOWW
| Q4 25 | 4.4% | 4.8% | ||
| Q3 25 | 2.8% | 5.8% | ||
| Q2 25 | 2.8% | 7.5% | ||
| Q1 25 | 3.0% | 6.5% | ||
| Q4 24 | 2.3% | 4.4% | ||
| Q3 24 | 0.5% | 10.4% | ||
| Q2 24 | 1.3% | 6.5% | ||
| Q1 24 | — | -5.7% |
现金转化率PLXPOWW
| Q4 25 | — | 2.55× | ||
| Q3 25 | -1.58× | 2.29× | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
POWW
暂无分部数据
